Conversations
Commercializing Breakthrough Research with Main Sequence's Mike Zimmerman
Mike Zimmerman is a co-founder and partner at Main Sequence, an early-stage deep tech fund investing in companies that commercialize breakthrough research from the Australian research ecosystem.